| Stage | CNP | % of rev | XEL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.2B | 100.00% | $4.2B | 100.00% | XEL ×1.90 |
| Gross profit | $1.3B | 57.33% | $2.3B | 54.79% | CNP +2.5pp |
| Operating income | $667M | 30.44% | $1.2B | 28.55% | CNP +1.9pp |
| Pre-tax income | $413M | 18.85% | $1.0B | 24.66% | XEL +5.8pp |
| Net income | $331M | 15.11% | $960M | 23.01% | XEL +7.9pp |
| Stage | CNP | XEL | Gap · A − B |
|---|---|---|---|
| Revenue | $2.2B100.00% | $4.2B100.00% | XEL ×1.90 |
| Gross profit | 57.33%$1.3B | 54.79%$2.3B | CNP +2.5pp |
| Operating income | 30.44%$667M | 28.55%$1.2B | CNP +1.9pp |
| Pre-tax income | 18.85%$413M | 24.66%$1.0B | XEL +5.8pp |
| Net income |
| 15.11%$331M |
| 23.01%$960M |
| XEL +7.9pp |
No shared counterparties.